SCHEMBL26102444

SCHEMBL26102444

Clc1ccc(CNc2ccc(Cc3ccncc3)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.57
LMNA P02545 3/20 0.55
MEN1 O00255 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
RECQL P46063 1/20 0.54
RAB9A P51151 1/20 0.54
KMT2A Q03164 1/20 0.54
CHEK1 O14757 1/20 0.54
MAP4K4 O95819 1/20 0.54
CHEK2 O96017 1/20 0.54
PRKCG P05129 1/20 0.54
PRKACA P17612 1/20 0.54
RPS6KB1 P23443 1/20 0.54
AKT1 P31749 1/20 0.54
FLT4 P35916 1/20 0.54
GSK3A P49840 1/20 0.54
GSK3B P49841 1/20 0.54
RPS6KA3 P51812 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5999682 0.93 KDR (0.59) HTTLMNAMEN1CYP1A2CYP2C9
SCHEMBL11512612 0.83 MEN1 (0.71) LMNAMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL19242049 0.83 KDM4E (0.61) HTTALDH1A1POLBMAPTKDM4E
SCHEMBL10945837 0.83 MEN1 (0.71) LMNAMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL1981719 0.83 HTT (0.59) HTTLMNARAB9AFLT1KDR
SCHEMBL11936087 0.83 CYP3A4 (0.62) HTTALDH1A1MAPTKDM4E
SCHEMBL19241691 0.79 F2 (0.56) HTTALDH1A1MAPTHDAC1KDM4E
SCHEMBL19242051 0.79 F2 (0.61) HTTRAB9ACHEK1MAP4K4CHEK2
Pyridine SCHEMBL28811103 0.78 HTT (0.60) HTTMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL19241983 0.77 KDM4E (0.56) HTTROCK1KDRALDH1A1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 HTT 1174/4885LMNA 2810/4885MEN1 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.